|M8973||Fevipiprant||Fevipiprant (QAW039) is a selective, potent, reversible competitive CRTh2 antagonist.|
|M8971||Grapiprant||Grapiprant is a novel, potent and selective prostaglandin EP4 receptor antagonist with antihyperalgesic properties.|
|M6138||E-7046||E7046 is an orally bioavailable and specific EP4 antagonist, with IC50 of 13.5 nM and Ki of 23.14 nM, exhibiting anti-tumor activities.|
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.